The Cancer Consortium

Cancer News & Information Center

Sunday, October 25th, 2026

Menu

  • Home
  • Members
    • Travera
    • Soligenix (SNGX)
    • NuView Life Sciences
  • News
    • MEMBER NEWS
    • FINDINGS
    • INDUSTRY
  • INTERVIEWS
    • CEOs
    • KOLs
  • Cancer Types
    • Breast Cancer
    • Cervical Cancer
    • Head and Neck Cancer
  • Database
  • About
    • Altru Cancer
    • Cancer Consortium
    • Newsletter
    • Research
  • RESOURCES
    • Foundations
    • Patient Resources
    • Media Resources

Bypassing Gastric Bypass Surgery

By Global Cancer Consortium on June 5, 2010 • ( 1 Comment )

A number of companies are developing minimally invasive devices that produce the weight-reducing effects of a gastric bypass minus the actual surgery.

Brain Cancer Vaccine Extends Survival Rate In Small Trial

By Global Cancer Consortium on June 2, 2010 • ( Leave a comment )

A brain cancer vaccine from Immunocellular Therapeutics has yielded positive results in a small Phase I clinical trial.

It’s a Tanning Spray. No, It’s a Surgical Glue.

By Global Cancer Consortium on June 1, 2010 • ( Leave a comment )

A compound found in sunless tanning spray may help heal post-surgical wounds.

Vertex Announces Positive Phase III Data for Hepatitis Drug

By Global Cancer Consortium on May 31, 2010 • ( Leave a comment )

The New York Times reports that about 75 percent of patients taking telaprevir in combination with existing hepatitis C drugs were essentially cured of the virus, compared to 44 percent on standard therapy alone.

Inhalable Drugs Let Patients Take a Breather from Needles

By Global Cancer Consortium on May 16, 2010 • ( Leave a comment )

Earlier this month, a team of researchers led by the University of Colorado at Boulder announced that the inhalable measles vaccine they developed could lead to vaccines for other diseases.

Treatment You Can Stick To

By Global Cancer Consortium on May 7, 2010 • ( Leave a comment )

Administering medication transdermally offers several advantages over other methods of drug delivery.

Specialty Pharmacies: Help for Chronic Care Patients

By Global Cancer Consortium on May 4, 2010 • ( Leave a comment )

With advances in medical care and drug development allowing those with acute conditions to live longer, it is expected there will be a greater need for specialty pharmacies

Ascites

By Global Cancer Consortium on May 3, 2010 • ( Leave a comment )

Medical Devices. The company is a medical devices company that has developed an implantable fluid pump used to treat the detrimental accumulation of serous body fluid, known as ascites. Ascites can arise […]

Posts navigation

‹ Newer 1 … 52 53 54 55 56 57 58 59 60 61 62 … 84 Older ›

INTERVIEWS »

INTERVIEW: Travera CEO Clifford Reid PhD

INTERVIEW: Soligenix CEO Christopher Schaber PhD.

INTERVIEW: Biden Cancer Initiative’s Greg Simon

PROFILES »

Gray Scale Images Convert to Detailed Color Images to Better Diagnose Breast Cancer

New Technology Using Light Therapy Kills Cells with No Side Effects

Real-time, In vivo Imaging Platform to Guide Surgeon During Cancer Surgery

Image result for cancer commons

Cancer Progress Report

Altru Cancer Progress Report June 2019

Subscribe to Cancer Progress Report

 

 

About Cancer Consortium

Members of the Global Cancer Consortium believe that progress occurs through collaboration which can occur through improved information.

This news site aggregates information and profiles of the member companies and organizations.

Its Cancer Progress Report reaches thousands of investors and industry professionals.

Global Cancer Consortium

The Cancer Consortium was formed by the Altru Cancer Project to offer one place to learn about the most promising developments, technologies and companies focused on Cancer.

 

 

  • Top categories: COMPANIES / cancer / Blog / feature2 / NEWS / Featured Articles / MEMBER NEWS / feature1 / Uncategorized / Member Spotlight
  • Top tags: cancer / breast cancer / diagnostics / oncology / prostate cancer / clarient / peter winter / brain cancer / melanoma / immunotherapy
Proudly powered by WordPress | Theme: Broadsheet by Pro Theme Design.